View printer-friendly version |
<< Back |
First Quarter Fiscal 2023 Highlights
-
Record quarterly net sales of
$658.3 million , a 103% increase compared with the same quarter last year, driven by record average conventional selling price and record specialty sales volume -
First quarter net income of
$125.3 million , or$2.58 per basic and$2.57 per diluted common share - First quarter gross profit margin of 33.0%
-
Announces first quarter fiscal 2023 cash dividend of
$0.85 per share
Overview
“Our operations ran well during the quarter, and we are pleased with our ability to manage the business despite significant inflationary pressures contributing to rising costs for feed, labor, packaging, and distribution, among other costs. We remain focused on the aspects of the business we can control with a shared commitment across Cal-Maine Foods’ operations to be the most efficient and sustainable producer of fresh shell eggs and egg products in the United States.”
“Egg prices continued to move higher during the quarter as supply tightened due to the impact of the highly pathogenic avian influenza (“HPAI”) outbreak and good customer demand for conventional eggs. Conventional egg net average selling price per dozen increased to
|
13 Weeks Ended |
||||||
|
|
|
|
||||
Dozen Eggs Sold (000) |
|
275,317 |
|
|
|
254,622 |
|
Conventional Dozen Eggs Sold (000) |
|
179,712 |
|
|
|
183,872 |
|
Specialty Dozen Eggs Sold (000) |
|
95,605 |
|
|
|
70,750 |
|
Dozen Eggs Produced (000) |
|
257,654 |
|
|
|
236,458 |
|
% Specialty Sales (dozen) |
|
34.7 |
% |
|
|
27.8 |
% |
% Specialty Sales (dollars) |
|
31.8 |
% |
|
|
42.0 |
% |
Net Average Selling Price (per dozen) |
$ |
2.275 |
|
|
$ |
1.235 |
|
Net Average Selling Price Conventional Eggs (per dozen) |
$ |
2.368 |
|
|
$ |
0.990 |
|
Net Average Selling Price Specialty Eggs (per dozen) |
$ |
2.101 |
|
|
$ |
1.872 |
|
Feed Cost (per dozen) |
$ |
0.667 |
|
|
$ |
0.545 |
|
Sales Performance & Operating Highlights
Net sales in the first quarter of fiscal 2023 were
For the first quarter of fiscal 2023, total dozens sold increased 8.1% to 275.3 million versus 254.6 million in the prior-year quarter, in part driven by strong sales volumes in the specialty eggs category. Conventional egg volumes sold decreased 2.3% compared with first quarter 2022, while specialty egg volumes sold increased by 35.1%. This increase in demand for specialty eggs was positively affected by the higher conventional egg prices as compared to the same period in the prior year. Demand was further positively affected by California’s and Massachusetts’ cage-free mandate going into effect
The Company reported operating income of
Product Mix & Cage-Free Eggs
Providing customers with a favorable product mix is an important differentiator for
A significant number of Cal-Maine Foods’ customers have previously announced goals to offer cage-free eggs exclusively on or before 2026, subject in most cases to availability of supply, affordability and customer demand, among other contingencies. Some of these customers have recently changed those goals to offer 70% cage-free eggs by the end of 2030. The Company’s customers typically do not commit to long-term purchases of specific quantities or types of eggs, and as a result, it is difficult to accurately predict customer requirements for cage-free eggs. The Company continues to engage with its customers in efforts to achieve a smooth transition toward meeting their announced goals and needs. Sales of cage-free eggs represented approximately 19.4% of shell egg revenues for the first quarter of fiscal 2023. Cage-free dozens sold increased 58% in the first quarter of fiscal 2023 as compared to the first quarter of fiscal 2022.
Table Egg Supply Outlook
Layer hen numbers reported by the
While no farm is immune from HPAI,
Dividend Payment
For first quarter 2023,
About
Forward Looking Statements
Statements contained in this press release that are not historical facts are forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. The forward-looking statements are based on management’s current intent, belief, expectations, estimates and projections regarding our company and our industry. These statements are not guarantees of future performance and involve risks, uncertainties, assumptions and other factors that are difficult to predict and may be beyond our control. The factors that could cause actual results to differ materially from those projected in the forward-looking statements include, among others, (i) the risk factors set forth in the Company’s
|
||||||||
|
||||||||
SUMMARY STATEMENTS OF OPERATIONS |
||||||||
|
||||||||
|
|
13 Weeks Ended |
||||||
|
|
|
|
|
||||
Net sales |
|
$ |
658,344 |
|
|
$ |
324,986 |
|
Cost of sales |
|
|
440,854 |
|
|
|
318,341 |
|
Gross profit |
|
|
217,490 |
|
|
|
6,645 |
|
Selling, general and administrative |
|
|
53,607 |
|
|
|
46,525 |
|
(Gain) loss on disposal of fixed assets |
|
|
33 |
|
|
|
(213 |
) |
Operating income (loss) |
|
|
163,850 |
|
|
|
(39,667 |
) |
Other income, net |
|
|
1,630 |
|
|
|
5,803 |
|
Income (loss) before income taxes |
|
|
165,480 |
|
|
|
(33,864 |
) |
Income tax expense (benefit) |
|
|
40,346 |
|
|
|
(15,838 |
) |
Net income (loss) |
|
|
125,134 |
|
|
|
(18,026 |
) |
Less: Loss attributable to noncontrolling interest |
|
|
(153 |
) |
|
|
— |
|
Net income (loss) attributable to |
|
$ |
125,287 |
|
|
$ |
(18,026 |
) |
|
|
|
|
|
|
|
||
Net income (loss) per common share: |
|
|
|
|
|
|
||
Basic |
|
$ |
2.58 |
|
|
$ |
(0.37 |
) |
Diluted |
|
$ |
2.57 |
|
|
$ |
(0.37 |
) |
Weighted average shares outstanding: |
|
|
|
|
|
|
||
Basic |
|
|
48,623 |
|
|
|
48,858 |
|
Diluted |
|
|
48,811 |
|
|
|
48,858 |
|
|
||||||
|
||||||
SUMMARY BALANCE SHEETS |
||||||
|
||||||
|
|
|
|
|
||
ASSETS |
|
|
|
|
|
|
Cash and short-term investments |
|
$ |
281,805 |
|
$ |
174,513 |
Receivables, net |
|
|
220,364 |
|
|
219,404 |
Inventories, net |
|
|
265,754 |
|
|
263,316 |
Prepaid expenses and other current assets |
|
|
10,965 |
|
|
4,286 |
Current assets |
|
|
778,888 |
|
|
661,519 |
|
|
|
|
|
|
|
Property, plant and equipment, net |
|
|
688,656 |
|
|
677,796 |
Other noncurrent assets |
|
|
87,185 |
|
|
88,174 |
Total assets |
|
$ |
1,554,729 |
|
$ |
1,427,489 |
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY |
|
|
|
|
|
|
Accounts payable and accrued expenses |
|
$ |
188,689 |
|
$ |
148,018 |
Dividends payable |
|
|
41,742 |
|
|
36,656 |
Current liabilities |
|
|
230,431 |
|
|
184,674 |
|
|
|
|
|
|
|
Deferred income taxes and other liabilities |
|
|
136,335 |
|
|
138,470 |
Stockholders' equity |
|
|
1,187,963 |
|
|
1,104,345 |
Total liabilities and stockholders' equity |
|
$ |
1,554,729 |
|
$ |
1,427,489 |
View source version on businesswire.com: https://www.businesswire.com/news/home/20220927006023/en/
(601) 948-6813
Source: